<DOC>
	<DOC>NCT00684424</DOC>
	<brief_summary>The primary efficacy parameter will be the responder rate, defined as the proportion of subjects who had at least a 50% reduction in 28 day seizure rate during the maintenance phase</brief_summary>
	<brief_title>Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>age over 18 years old, patients with epilepsia with partial seizures Enrollment to study is fully on physician decision in compliance with current SPC. Patient who did not meet indication according to SPC Lyrica</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>